Literature DB >> 17200773

Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles.

David M Smalley1, Karen E Root, Hyungjun Cho, Mark M Ross, Klaus Ley.   

Abstract

Microparticles (MPs) are small membrane vesicles generated by essentially all cell types. In the plasma, most MPs are derived from platelets, but those from other sources, particularly leukocytes (macrophages, lymphocytes, and neutrophils), endothelial cells, and even smooth muscle cells can be detected and appear to play an important role in normal physiology and various diseases. In previous work we analyzed the proteome of MPs generated from isolated platelets (platelet MPs). Here, we report on a comparative analysis of microparticles isolated from plasma (plasma MPs) versus platelet MP using two complementary methods of comparative analysis. The first method, spectral count analysis, yielded 21 proteins detected in plasma MPs (with a total spectral count of 10 or greater) that were essentially absent in platelet MPs (with a total spectral count of 1 or 0). An additional two proteins (von Willebrand Factor, albumin) were present in both types of MPs but enriched in the plasma MPs. The second method, isotope-coded affinity tag (ICAT) labeling of proteins, supported the spectral count results for the more abundant proteins and provided better relative quantitation of differentially expressed proteins. Proteins present only in the plasma MPs include several associated with apoptosis (CD5-like antigen, galectin 3 binding protein, several complement components), iron transport (transferrin, transferrin receptor, haptoglobin), immune response (complement components, immunoglobulin J and kappa chains), and the coagulation process (protein S, coagulation factor VIII).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17200773

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  24 in total

Review 1.  Microparticles as mediators and biomarkers of rheumatic disease.

Authors:  David S Pisetsky; Anirudh J Ullal; Julie Gauley; Tony C Ning
Journal:  Rheumatology (Oxford)       Date:  2012-03-07       Impact factor: 7.580

2.  Techniques to improve detection and analysis of extracellular vesicles using flow cytometry.

Authors:  Heather C Inglis; Ali Danesh; Avani Shah; Jacques Lacroix; Philip C Spinella; Philip J Norris
Journal:  Cytometry A       Date:  2015-04-02       Impact factor: 4.355

3.  Techniques for the analysis of extracellular vesicles using flow cytometry.

Authors:  Heather Inglis; Philip Norris; Ali Danesh
Journal:  J Vis Exp       Date:  2015-03-17       Impact factor: 1.355

Review 4.  Extracellular vesicles and blood diseases.

Authors:  Shosaku Nomura
Journal:  Int J Hematol       Date:  2017-01-27       Impact factor: 2.490

5.  Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification.

Authors:  Michal Harel; Pazit Oren-Giladi; Orit Kaidar-Person; Yuval Shaked; Tamar Geiger
Journal:  Mol Cell Proteomics       Date:  2015-01-26       Impact factor: 5.911

6.  Proteomics of microparticles after deep venous thrombosis.

Authors:  Eduardo Ramacciotti; Angela E Hawley; Shirley K Wrobleski; Daniel D Myers; John R Strahler; Philip C Andrews; Kenneth E Guire; Peter K Henke; Thomas W Wakefield
Journal:  Thromb Res       Date:  2010-02-13       Impact factor: 3.944

Review 7.  Do galectins play a role in venous thrombosis? a review.

Authors:  Jose A Diaz; Eduardo Ramacciotti; Thomas W Wakefield
Journal:  Thromb Res       Date:  2009-12-02       Impact factor: 3.944

8.  Circulating endothelial microparticles in diabetes mellitus.

Authors:  A F Tramontano; R Lyubarova; J Tsiakos; T Palaia; J R Deleon; L Ragolia
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

9.  CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation.

Authors:  Yara Banz; Guido Beldi; Yan Wu; Ben Atkinson; Anny Usheva; Simon C Robson
Journal:  Br J Haematol       Date:  2008-06-05       Impact factor: 6.998

10.  MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides.

Authors:  Xu Yang; Iulia M Lazar
Journal:  BMC Cancer       Date:  2009-03-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.